2026. Validity and Reability Test of the Naranjo Questionnaire to Measure Adverse Drug Reactions (ADRs) in Atherosclerosis Patients. Biocity Journal of Pharmacy Bioscience and Clinical Community. 4, 2 (Apr. 2026), 43–50. DOI:https://doi.org/10.30812/biocity.v4i2.5842.